Iohexol injection
Closed Solicitation Posted
- Solicitation number
- SPE2DP26T5366
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- More information
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical Supply Chain seeks quotes for two boxes of Iohexol Injection (NSN 6505-01-665-9178) under RFQ SPE2DP26T5366, with quotes due October 8, 2026. The solicitation carries no set-aside and is a Fast Auto Evaluation issued by DLA office SPE2DP, with quotes submitted through DIBBS. One description entry lists October 5, 2026, but the later entry and the structured due date set October 8, 2026 as current.
Delivery is required within five days, FOB Destination, with inspection and acceptance at destination. The attached RFQ, as summarized in the notice, names delivery to the Naval Amphibious Assault Carrier USS Bougainville (LHA 8) at Gulfport, Mississippi.
The item must be stored at controlled room temperature (20-25C, with excursions to 15-30C), carry a non-extendable 36-month shelf life, and be classified as TYPE I (CODE Q). The attachment requires that the item be supplied by GE Healthcare Inc. (CAGE 0AY96, P/N NDC00407-1413-65). Packaging must comply with Medical Marking Standard No. 1 rather than MIL-STD-129. If the material is hazardous under Federal Standard 313, suppliers must provide Safety Data Sheets per 29 CFR 1910.1200. Applicable DFARS clauses cover Buy American compliance, hazard warning labels, U.S.-flag sea transport, and covered defense telecommunications equipment prohibitions.
The notice does not state an award value or ceiling. Procurement history shows prior awards to CAGE 0AY96 at a unit price of $92.67, in 2023 and earlier. The attachment summary lists NAICS 424210, with a 500-employee size standard for non-manufacturers.
Notice text
2 versions
Update #2 · Latest ·
DLA request for quotation SPE2DP26T5366, issued by DLA office SPE2DP through DIBBS. Quotes are due by 10/08/2026. Set-aside: No Set-Aside Used. Solicitation type: Fast Auto Evaluation. FOB Destination. Inspection at Destination. Item: line 0001, IOHEXOL INJECTION, NSN 6505-01-665-9178, 2 BX, delivery in 5 days, PR 7018563519. Quotes must be submitted via DIBBS.
Update #1 ·
DLA request for quotation SPE2DP26T5366, issued by DLA office SPE2DP through DIBBS. Quotes are due by 10/05/2026. Set-aside: No Set-Aside Used. Solicitation type: Fast Auto Evaluation. FOB Destination. Inspection at Destination. Item: line 0001, IOHEXOL INJECTION, NSN 6505-01-665-9178, 2 BX, delivery in 5 days, PR 7018563519. Quotes must be submitted via DIBBS.
Files
| File | Type | Posted |
|---|---|---|
| SPE2DP26T5366.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Control,hemoglobin | Medical Supply Chain | No set-aside | |
| Injector,intraosseous | Medical Supply Chain | No set-aside | |
| Sodium chloride injec | Medical Supply Chain | No set-aside | |
| Control,blood chemist | Medical Supply Chain | No set-aside | |
| Sodium chloride injec | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity